Health Data Sweden

HDS is the one stop shop for acceleration of digital transformation in health data for SME’s and the public sector using key technologies.

European Digital Innovation Hubs (EDIH:s) provide technical expertise and testing to enable digital transformation for the public sector and SMEs with funding from EU Digital. Health Data Sweden (HDS) is a Swedish EDIH with a focus on health data. HDS is a three-year project that started in 2023 with co-funding from the European Regional Development Fund and Vinnova and where KTH is the coordinator.

Health Data Sweden (HDS) is a national initiative that consists of 16 partners, including universities, regions, innovation environments, and research institutes. Stockholm Science City Foundation is one of these parties and is responsible, among other things, for building up the ecosystem. The digital innovation hub's strength will be cutting-edge research in the field of health data combined with an ecosystem consisting of the parties' networks. Through HDS, competence and service provision will convey knowledge to the public sector, businesses, and, finally, citizens.

The budget for HDS is six million euros spread over three years and is to be used, among other things, to speed up the use of health data to contribute to more efficient healthcare. One way to do that is to meet the great need for services that also enable small and medium-sized enterprises to develop new digital health and welfare services in collaboration with the public sector. In addition to better health for the individual, these services can contribute to solving major demographic societal challenges, for example, by making healthcare more accessible and equal.

Sweden has a prominent position in both health innovation and the use of health data, and the project aims to strengthen this role by improving national collaboration. There is a need for an ecosystem that includes all major stakeholders and where cutting-edge knowledge, data access, testbeds, and early funding become available as services for both the public sector and small and medium-sized enterprises in Sweden and the EU.

Key technologies
HDS has established a coordinated knowledge base for Swedish and European stakeholders and testbeds that work with health data. This is carried out with technical expertise in:

  1. Artificial Intelligence (AI)
  2. Cyber Security
  3. High-Performance Computing (HPC)

Digital service catalog 
HDS provides services relevant to health data within five core offers;

  1. Skills and training
  2. Support to finance
  3. Ecosystem
  4. Test before investing
  5. Health data development

By providing access to technical expertise and testing, HDS will help companies to improve business/production processes, products, and services using digital technologies. Innovation services, e.g., financing advice, training, and skills development needed for successful digital transformation, is also offered. A digital catalog will collect all these services, more information on the HDS website >>

Health data
Health data is all data that can provide information relevant to human health. It can be anything from clinical data from hospitals and doctors via gene and protein data to lifestyle habits.

Contact Stockholm Science City: Filippa Kull, Business Development Director filippa.kull@ssci.se
Contact KTH: Sebastiaan Meijer, Professor in Health Care Logistics smeijer@kth.se

Sebastiaan Meijer about the project (Swedish) >>

 

Partners

 

 

 

 

 

 

They improve women's quality of life through appreciated app

The femtech company Ovulai develops a digital treatment app for women with chronic gynecological diseases. The team shares a passion for improving an under-prioritized area; women's health. They are data-driven women of tech, and most of them have studied at KTH.

"I enjoy seeing the direct results of my work"

Since a couple of months Peter Hovstadius is the new Chief Medical Officer at XNK Therapeutics, responsible for leading the medical development of the company's products. XNK operates in biotechnology and develops cell therapies (ATMP) using natural killer cells (NK cells) for cancer treatment. 

Subscribe to